PR Newswire US, January 18, 2007, Thursday

Copyright 2007 PR Newswire Association LLC.

All Rights Reserved.

PR Newswire US

January 18, 2007 Thursday 2:28 PM GMT

HEADLINE: Alpharma Names Executive Vice President, Human Resources and Communication

DATELINE: FORT LEE, N.J. Jan. 18

BODY:

FORT LEE, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Alpharma Inc. (NYSE:ALO), a leading global specialty pharmaceutical company announced today that Peter M. Watts has joined the company as Executive Vice President, Human Resources and Communications reporting directly to Dean Mitchell, President and Chief Executive Officer. Mr. Watts has over 20 years of experience in U.S. and International human resources management and consulting, including key roles at Novartis and Warner-Lambert. Prior to joining Alpharma, Mr. Watts was the Senior Vice President, Human Resources and Employee Services at Scholastic Corporation.

"I am pleased to add a human resources executive of Peter's talent and experience to the Alpharma management team," commented Dean Mitchell, President and Chief Executive Officer. "In order to achieve the ambitious growth objectives the company is targeting, a top company priority is to attract, retain and develop the best talent available. I am confident that Peter's skill, energy, and vision will result in the creation of a team well equipped to execute the company's growth initiatives."

Prior to his role at Scholastic, Mr. Watts held several key human resources positions in the pharmaceutical industry, including Vice President, Human Resources, for the U.S. Pharmaceutical business of Novartis and Vice President, Human Resources - Europe, at Warner-Lambert. His consulting experience included clients such as Warner-Chilcott, Cardinal Health, Oak Hill Capital, and Bank of America.

Mr. Watts is a graduate of Cornell University in Industrial and Labor Relations and earned an MBA with honors from Columbia Business School.

Alpharma press releases are also available at our website: http://www.alpharma.com/ .

Alpharma Inc. (NYSE:ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

CONTACT: Kathleen Makrakis - VP, Investor Relations, +1-201-228-5085,

kathleen.makrakis@alpharma.com

Web site: http://www.alpharma.com/

SOURCE Alpharma Inc.